首页|多索茶碱、布地奈德、心理干预联合治疗支气管哮喘效果观察

多索茶碱、布地奈德、心理干预联合治疗支气管哮喘效果观察

扫码查看
目的 观察多索茶碱、布地奈德、心理干预联合在治疗支气管哮喘中的应用,评价其临床效果.方法 对本院2014年3月~2017年2月收治的148例支气管哮喘患者临床资料进行回顾性分析,采用双盲数字表随机法分为参照组与试验组各74例.参照组患者均给予多索茶碱、布地奈德联合治疗+常规护理干预,试验组在参照组基础上加入心理干预,比较2组患者临床治疗情况.结果 试验组治疗总有效率为95.95%(71/74),参照组为79.73%(59/74),二者间差异具有统计学意义(P<0.05);较之治疗前,2组患者治疗后FEV1、FVC、VC等指标均明显改善,且试验组改善效果明显优于参照组(P<0.05).结论 多索茶碱、布地奈德、心理干预联合应用于支气管哮喘的治疗中疗效显著,可有效改善患者肺功能情况,加速症状消失时间,具有应用与推广价值.
Observation on the effect of doxofylline, budesonide and psychological intervention on the treatment of the patients withbronchial asthma
Objective To observe the effect of doxofylline and budesonide combined with psychological intervention on the treatment of the patients with bronchial asthma, and evaluate its clinical effect. Methods From March 2014 to February 2017 in Guangfu hospital, 148 cases with bronchial asthma were divided into the control group and the experimental group by randomized double blind digit table with 74 cases in each group. The control group were given doxofylline and budesonide combined with routine nursing intervention, at this basis, the experimental group were receive psychological intervention. The clinical effect in the two groups were compared. Results The total effective rate was 95.95% (71/74) in the experimental group while 79.73%(59/74) in the control group, the difference was statistically significant between the two groups(P<0.05); Compared with before treatment, FEV1, FVC, VC and other indicators after treatment were significantly improved, and the experimental group improved significantly better than those in the control group (P<0.05). Conclusion Doxofylline and budesonide combined with psychological intervention on the treatment of the patients with bronchial asthma has obvious curative effect, which can effectively improve the lung function, accelerate the symptoms disappeared time, and worthy of clinical application.

doxofyllinebudesonidepsychological interventionbronchial asthma

姜福仙、王美、上官丽仙

展开 >

金华市广福医院 呼吸科,浙江 金华 321000

金华市广福医院 老年医学科,浙江 金华 321000

多索茶碱 布地奈德 心理干预 支气管哮喘

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(8)
  • 12
  • 8